SEARCH

SEARCH BY CITATION

References

  • 1
    de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768
  • 2
    Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. HEPATOLOGY 2007; 46: 922-938
  • 3
    Irani S. Kowdley K. Kozarek R. Gastric varices: an updated review of management. J Clin Gastroenterol 2011; 45: 133-148
  • 4
    Choudhuri G, Chetri K, Bhat G, Alexander D, Das K, Ghoshal UC, et al. Long-term efficacy and safety of N-butylcyanoacrylate in endoscopic treatment of gastric varices Trop Gastroenterol 2010; 31: 155-164.
  • 5
    Cheng LF, Wang ZQ, Li CZ, Lin W, Yeo AET, Jin B. Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol 2010; 8: 760-766.
  • 6
    Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. HEPATOLOGY 2001; 33: 1060-1064.
  • 7
    Tan PC, Hou MC, Lin HC, Liu TT, Lee FY, Chang FY, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. HEPATOLOGY 2006; 43: 690-7.
  • 8
    El Amin H, Abdel Baky L, Sayed Z, Abdel Mohsen E, Eid K, Fouad Y, et al. A randomized trial of endoscopic variceal ligation versus cyanoacrylate injection for treatment of bleeding junctional varices. Trop Gastroenterol 2010; 31: 279-284.
  • 9
    Mishra SR, Sharma BC, Kumar A, Sarin SK. Endoscopic cyanoacrylate injection versus b-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial. Gut 2010; 59: 729-735.
  • 10
    Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007; 39: 679-685.
  • 11
    Procaccini N, Al-Osaimi AMS, Northup P, Argo C, Caldwell SH. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis. Gastrointest Endosc 2009; 70: 881-887.
  • 12
    Mahadeva S, Bellamy MC, Kessel D, Davies MH, Millson CE. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol. 2003; 98: 2688-2693.
    Direct Link:
  • 13
    Akahoshi T, Hashizume M, Tomikawa M, Kawanaka H, Yamaguchi S, Konishi K, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol 2008; 23: 1702-1709.
  • 14
    Sabri SS, Swee W, Turba UC, Saad WE, Park AW, Al Osaimi AM, et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol 2011; 22: 309-316.
  • 15
    Cho SK, Shin SW, Lee IH, Do YS, Choo SW, Park KB, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol 2007; 189: W365-W372.
  • 16
    Ninoi T, Nishida N, Kaminou T, Sakai Y, Kitayama T, Hamuro M, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol 2005; 184: 1340-1346.
  • 17
    Kasuga A, Mizumoto H, Matsutani S, Kobayashi A, Endo T, Ando T, et al. Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration. J Hepatobiliary Pancreat Sci 2010; 17: 898-903.
  • 18
    Uehara H, Akahoshi T, Tomikawa M, Kinjo M, Hashimoto N, Nagao Y, et al. Prediction of improved liver function after balloon-occluded retrograde transvenous obliteration: relation to hepatic vein pressure gradient. J Gastroenterol Hepatol 2012; 27: 137-141.